Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Multicenter, Open-Label, Dose Escalation Trial of AS703569 Given Orally to Subjects With Solid Tumours

NCT00391521 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT00391521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Multicenter, Open-Label, Dose Escalation Trial of AS703569 Given Orally to Subjects With Solid Tumours
Lead sponsor
EMD Serono
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2006
Completion date
June 30, 2010
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors